After 48 h, cultures were pulsed with 0.4 μCi [3H]thymidine (Amersham Biosciences, Braunschweig, Germany),

and incubated for another 24 h. After harvesting, incorporated DNA was measured in a β-counter (Perkin Elmer, Rodgau, Germany). Cytotoxicity of freshly sorted splenic CXCR3− and CXCR3+ NK cells Fostamatinib ic50 (5×105/mL) against YAC-1 target cells was assessed by standard 4 h chromium release assay. Target cells were labeled with 3 MBq Na51CrO4 (Hartmann Analytic, Braunschweig, Germany), incubated for 1 h at 37°C, washed two times and used for the assay within 1 h. Cells were plated in V-bottom 96-well plates. Background values were determined by incubating target cells without effector cells. Maximal values were obtained by lysing target cells with 1% Triton X-100 (Sigma-Aldrich).

After 4 h, cells were pelleted and 100 μL supernatant of each well was used for measurement of 51Cr release in a γ counter (MicroBeta/PerkinElmer, Waltham, MA, USA) in triplicates with E:T ratios of 10:1, 5:1, 2.5:1 and 1.25:1. Specific lysis was calculated by: [(experimental release–spontaneous release)/(maximum release–spontaneous release)] ×100. Lysosomal granule exocytosis was determined by CD107a expression. For this experiment, lymphocytes (E:T ratio 10:1) or sorted CXCR3− and CXCR3+ NK cells (E:T ratio 2:1) were incubated at 37°C in 5% CO2 together Buparlisib ic50 with YAC-1 cells for 4 h. Anti-CD107a mAb was added directly Baricitinib to the cell suspensions at a final concentration of 0.01 mg/mL. After 1 h of incubation, Monensin (BD Biosciences) was added as a golgi block at a final concentration of 5 μg/mL and incubation was continued for additional 3 h. In case of subsequent intracellular cytokine staining, brefeldin A (Sigma-Aldrich) was added at a final concentration of 2 μg/mL for the last 3 h of incubation time. Samples were finally surface-stained and analyzed via multicolor flow cytometry. In order to determine the IFN-γ production, sorted

CXCR3− and CXCR3+ NK cells were cultured in 96-well round-bottom culture plates (Greiner, Frickenhausen, Germany) in the presence of rIL-2 (100 U/mL), rIL-12 (10 ng/mL) and rIL-18 (5 ng/mL) for 15–17 h. Optimal cytokine concentrations were determined by earlier dose titrations. Brefeldin A (Sigma-Aldrich) was added at a final concentration of 2 μg/mL for the last 2 h of incubation time. Analysis of intracellular IFN-γ was preceded by surface staining at 4°C. After 30 min, cells were washed twice and resuspended in PBS containing 3% FCS. After fixation with 4% paraformaldehyde (Merck) for 10 min, cells were perforated with 0.1% saponin buffer (PBS supplemented with 0.1% saponin (Riedel-de Haën, Seelze, Germany) and 0.01 M HEPES (Roth, Karlsruhe, Germany)) and anti-IFN-γ mAb was added. After 30 min of incubation and three washes, cells were analyzed as described above.